Projects

A data-driven approach to deciphering the genomic landscape of recessively inherited kidney diseases in Indian population using the Genome India database and developing a novel in-vivo assay for elucidating pathogenicity of rare variants in common genes causing renal tubular disorders

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2028

Project Lead

Dr. Anil Vasudevan

Authors

Dr. Anil Vasudevan, Dr. Raghu Padinjat & Dr. Ambily Sivadas

Project Status

ongoing

Project Type

DBT funded